Skip to content
    IMDX stock page

    Insight Molecular Diagnostics Inc.

    IMDX · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 10, 2026

      Insight Molecular Diagnostics Q2 FY26 — GraftAssureDx FDA Authorization Nearing & Market Expansion

      Read the brief

    Browse all US companies on the earnings-call register.